← All organizations
Albert Einstein Israelite Hospital
Academic/HospitalWebsite ↗
Also known as: Academic Research Organization -- Hospital Israelita Albert Einstein | Hospital Albert Einstein | Hospital Israelita Albert Einstein | Hospital Israelita Albert Einstein- Oncological Unit | Hospital Israelita Albert Einstein- Research Institute | Hospital Israelita Albert Eisntein | MD
Highest phase reached
Phase 4
First clinical trial
May 1, 2010Last known activity
Feb 1, 2026
Timeline
1950s
- Jan 1, 1955
Albert Einstein Israelite Hospital— Founded
Drugs by trial phase (64 distinct, 50 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (24 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Lung Injury
- Attention Deficit Disorder with Hyperactivity
- Cancer Pain
- Carcinoma, Non-Small-Cell Lung
- Coronavirus Infections
- Graft vs Host Disease
- Hyperhidrosis
- Infections
- Influenza, Human
- Lactose Intolerance
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lung Neoplasms
- Migraine Disorders
- Musculoskeletal Pain
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Pneumonia
- Pneumonia, Viral
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Severe Acute Respiratory Syndrome
- Syndrome
- Venous Insufficiency
- Virus Diseases
Recent trials (50)
- NCT07064564OfficialPhase 1Feb 1, 2026
- NCT07101822Lead sponsorPhase 2Dec 31, 2025
- NCT07233837Lead sponsorN/ANov 17, 2025
- NCT07233837OfficialN/ANov 17, 2025
- NCT07101848Lead sponsorPhase 2Nov 1, 2025
- NCT06453122OfficialN/AMar 15, 2024
- NCT06453122Lead sponsorN/AMar 15, 2024
- NCT05954559Overall official - principal investigatorPhase 4Jan 31, 2024
- NCT05920005Lead sponsorPhase 3Aug 22, 2023
- NCT05920005Study directorPhase 3Aug 22, 2023
- NCT06011486Overall official - principal investigatorPhase 1Jun 10, 2023
- NCT06011486Lead sponsorPhase 1Jun 10, 2023
- NCT05705570Overall official - principal investigatorPhase 1Mar 1, 2023
- NCT05705570Lead sponsorPhase 1Mar 1, 2023
- NCT05767723Lead sponsorPhase 4Feb 6, 2023
Details
- Founded
- Sao Paulo, BR Jan 1, 1955
- Last known activity
- Feb 1, 2026